Clifford Swan Investment Counsel LLC Pfizer Inc Transaction History

Clifford Swan Investment Counsel LLC

$2.78 Billion
Q3 2024

A detailed history of Clifford Swan Investment Counsel LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 554,345 shares of PFE stock, worth $14.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

554,345

Previous 519,790 6.65%

Holding current value

$14.6 Million

Previous $14.5 Million 10.31%

% of portfolio

0.58%

Previous 0.55%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $957,173 - $1.08 Million	34,555 Added 6.65%	554,345 $16 Million
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $74,138 - $86,876	2,935 Added 0.57%	519,790 $14.5 Million
Q1 2024 Apr 16, 2024	BUY	$25.89 - $29.73 $2.58 Million - $2.97 Million	99,785 Added 23.93%	516,855 $14.3 Million
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $486,305 - $631,657	18,611 Added 4.67%	417,070 $12 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $31,512 - $36,834	982 Added 0.25%	398,459 $13.2 Million
Q2 2023 Aug 03, 2023	SELL	$36.12 - $41.79 $72,890 - $84,332	-2,018 Reduced 0.51%	397,477 $14.6 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $255,838 - $333,063	-6,495 Reduced 1.6%	399,495 $16.3 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $26,970 - $35,207	-646 Reduced 0.16%	405,990 $20.8 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $265,404 - $323,992	-6,065 Reduced 1.47%	406,636 $17.8 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $352,092 - $417,471	-7,567 Reduced 1.8%	412,701 $21.6 Million
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $22,509 - $27,891	492 Added 0.12%	420,268 $21.8 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $56,938 - $84,402	-1,378 Reduced 0.33%	419,776 $24.8 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $912,523 - $1.17 Million	-23,249 Reduced 5.23%	421,154 $18.1 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $950,250 - $1.08 Million	-26,462 Reduced 5.62%	444,403 $20.1 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $898,570 - $1.01 Million	26,831 Added 6.04%	470,865 $17.1 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $377,340 - $479,821	-11,274 Reduced 2.48%	444,034 $16.3 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $124,968 - $146,616	-3,936 Reduced 0.86%	455,308 $16.7 Million
Q2 2020 Aug 06, 2020	SELL	$30.12 - $36.54 $179,695 - $217,997	-5,966 Reduced 1.28%	459,244 $15 Million
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $38,490 - $54,994	1,424 Added 0.31%	465,210 $15.2 Million
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $30,023 - $34,072	-912 Reduced 0.2%	463,786 $18.2 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $368,664 - $478,049	11,347 Added 2.5%	464,698 $16.7 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $146,255 - $164,211	-3,955 Reduced 0.86%	453,351 $19.6 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $323,850 - $355,803	-8,636 Reduced 1.85%	457,306 $19.4 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $1.05 Million - $1.2 Million	-27,325 Reduced 5.54%	465,942 $20.3 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $351,214 - $426,002	-10,189 Reduced 2.02%	493,267 $21.7 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $208,862 - $222,668	-6,333 Reduced 1.24%	503,456 $18.3 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $994,889 - $1.15 Million	31,178 Added 6.51%	509,789 $18.1 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $359,108 - $381,026	-10,797 Reduced 2.21%	478,611 $17.3 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $32,519 - $35,823	-1,049 Reduced 0.21%	489,408 $17.5 Million
Q2 2017 Aug 11, 2017	BUY	N/A	490,457	490,457 $16.5 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.

Account

Clifford Swan Investment Counsel LLC Pfizer Inc Transaction History